Lifecore Biomedical, Inc. LFCR

4.20 (0.09) (2.10%) as of 25 Sep
Market cap
$162.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

May '25 May '24 May '23 May '22 May '21 May '20 May '19 May '18 May '17 May '16
Cash and Short Term Investments
8.27 8.46 19.09 0.99 1.16 0.36 1.08 2.90 6.00 9.89
Receivables
28.69 27.08 29.02 38.31 41.43 76.21 69.57 53.88 45.90 46.41
Inventory
32.29 39.98 40.84 36.00 63.08 66.31 54.13 31.82 23.62 25.54
Other current assets
6.98 4.07 5.08 7.05 42.66 14.23 6.26 8.47 5.76 4.47
Total current assets
85.68 81.03 93.88 116.67 148.32 157.11 133.04 97.06 81.28 86.30
Property, Plant, Equpment (Net)
129.01 149.17 134.39 118.67 120.29 192.34 200.03 159.62 133.22 120.88
Long-Term Investments
— — — — 45.10 56.90 61.10 66.50 63.60 62.70
Goodwill and Intangible Assets (Total)
18.08 18.08 18.08 18.08 59.55 107.49 121.99 76.35 77.32 71.02
Long-term assets (Other)
6.58 5.68 2.92 2.89 3.53 2.16 2.93 5.16 2.92 1.75
Total non-current assets
153.67 172.93 159.67 158.04 354.60 384.21 386.05 307.64 277.33 256.35
Total Assets
239.34 253.96 253.55 274.70 502.92 541.31 519.09 404.70 358.61 342.65
Accounts Payable
8.22 16.33 22.10 12.95 16.30 51.65 53.97 34.67 24.53 30.90
Accrued Expenses
21.96 22.54 4.15 8.94 7.75 9.03 10.69 9.98 7.51 5.46
Current Part of Debt
— 0.77 0.58 138.18 29.00 88.95 61.79 31.94 7.94 11.37
Current Revenue (Deferred)
— 2.11 4.06 0.92 0.64 0.35 0.50 2.63 0.31 0.83
Total current liabilities
30.18 38.87 39.29 176.58 101.89 164.39 137.09 88.38 51.45 56.34
Long Term Debt (Total)
151.99 149.13 165.97 9.98 164.90 101.36 87.19 41.00 46.03 49.78
Non-current Revenue (Deferred)
— 4.70 2.94 — — — — — — —
Long Term Tax Liability (Deferred)
— 0.54 0.38 0.13 6.14 13.59 19.39 17.49 24.58 22.44
Non-current Liabilities (Other)
9.74 12.06 0.17 0.19 2.87 4.55 1.74 5.28 8.39 1.74
Total non-current liabilities
161.73 161.19 179.17 10.30 198.25 145.88 111.86 63.77 79.00 73.96
Total liabilities
191.91 200.06 218.46 186.88 300.14 310.27 248.95 152.14 130.46 130.30
Additional Paid In Capital
206.54 177.81 174.28 167.35 165.53 162.58 160.34 142.09 141.68 137.24
Preferred Stock (Total)
46.10 42.59 39.32 — — — — — — —
Common Stock (Net)
0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03
Retained Earnings
(205.24) (166.52) (178.54) (78.97) 38.58 71.25 109.71 109.30 84.47 73.46
Common Equity (Total)
1.34 11.32 (4.23) 87.82 202.78 231.04 270.14 252.56 228.15 212.35
Shareholders Equity (Total)
47.43 53.90 35.09 87.82 202.78 231.04 270.14 252.56 228.15 212.35
Shareholders Equity and Liabilities (Total)
239.34 253.96 253.55 274.70 502.92 541.31 519.09 404.70 358.61 342.65
Shares (Common)
37.03 30.56 30.32 29.51 29.33 29.22 29.10 27.70 27.50 27.15
Shares (Preferred)
0.05 0.04 0.04 0.04 — — — — — —
Shareholders Equity (Tangible)
29.35 35.82 17.01 69.74 143.24 123.55 148.16 176.21 150.83 141.33
Net Debt
143.73 141.44 147.45 147.17 192.74 189.96 147.90 70.04 47.97 51.26
Total Debt
151.99 149.90 166.55 148.16 193.90 190.32 148.98 72.94 53.97 61.15

Fold the line items

In millions of $ except per-share values · columns are period end dates